Dr. Raymond A. Huml,

Raymond Huml is a dedicated and versatile professional with over 25 years of experience in the healthcare and biopharmaceutical industries. His career spans patient-centric drug development, bioinformatics, and DEI advocacy, with a focus on driving innovation and improving patient outcomes. Raymond has held global leadership roles, including spearheading a rare disease consortium and a biosimilars center of excellence, and as a certified regulatory affairs professional, he has evaluated billions of dollars in opportunities and contributed to securing hundreds of millions in risk-based and fee-for-service partnerships.

His expertise extends to due diligence, third-party capital advisory, and risk-based investing, complementing his role as a passionate patient advocate and rare disease parent. Licensed as a veterinarian and with experience as a wildlife biologist, Raymond brings a unique, multidisciplinary perspective to his work—further enriched by his service as a returned US Peace Corps volunteer. His career reflects a commitment to advancing clinical trials, drug development, and meaningful patient impact globally.